Palliative Care and Characterization of Symptoms in Patients Undergoing Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy.
Palliative Care and Characterization of Symptoms in Patients Undergoing Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy.
复制标题
接受细胞减灭手术/腹腔高温化疗患者的姑息治疗和症状特征。
DOI:
10.1016/j.jss.2022.11.061
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Eng,OliverS
中科院分区:
文献类型:
--
作者:
Sneider,AbigailP;Dhiman,Ankit;Sood,Divya;Ong,Cecilia;Tun,Sandy;Malec,Monica;Levine,Stacie;Turaga,KiranK;Eng,OliverS
IntroductionPalliative care for advanced cancer patients has been associated with improvements in symptom management and quality of life (QoL). Patients with peritoneal metastases undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) often report symptoms adversely affecting QoL. We characterized and compared symptoms elucidated by palliative careversussurgical providers in this setting.MethodsCRS/HIPEC patients who saw both surgical oncology and palliative care providers from 2016 to 2020 at a tertiary care center were identified from a retrospective database. Documentation of QoL-associated symptoms in surgical oncology and palliative care visits was recorded and analyzed.ResultsA total of 118 patients were included in this study. The most common primary histologies were appendiceal (36.4%) and colorectal (28.8%). Symptoms most frequently reported by palliative care were pain (60.2%) and fatigue (54.2%). The median number of symptoms documented was three (2, 5) in palliative care notes and two (0, 3) in surgical oncology notes (P< 0.001). Palliative care providers documented most symptoms statistically more frequently than surgical oncology providers.ConclusionsPatients who underwent CRS/HIPEC experienced various QoL-associated symptoms. Palliative care providers elicited more symptoms than surgical oncology providers. Additional studies are needed to explore the impact on outcomes of perioperative palliative care in this challenging patient population.